Conference Coverage

MedPAC urges CMS to curb low-value care


 

REPORTING FROM MEDPAC


Commissioner Jack Hoadley, PhD, of Georgetown University in Washington, cautioned that any discussion on these or possibly other tools needs to take into account the needs of those who will legitimately benefit from some of the low-value services so they do not inadvertently prevent access for those patients.

At press time, MedPAC had not scheduled a vote on specific recommendations to address low-value care.

Pages

Recommended Reading

Medicare Part D plans get more flexibility to make midyear changes
MDedge Rheumatology
MDedge Daily News: Could gut bacteria trigger lupus?
MDedge Rheumatology
Open enrollment 2018: Plan selections down slightly
MDedge Rheumatology
MDedge Daily News: Antibiotic resistance leads to ‘nightmare’ bacteria
MDedge Rheumatology
CMS finalizes measures to help combat opioid crisis
MDedge Rheumatology
Health IT ‘under-users’ outnumber ‘super-users’
MDedge Rheumatology
Patient advocacy groups take in millions from drugmakers. Is there a payback?
MDedge Rheumatology
Pregnant women in clinical trials: FDA questions how to include them
MDedge Rheumatology
MDedge Daily News: Skin disorders defeat weekend warriors
MDedge Rheumatology
MDedge Daily News: Time to let more pregnant women into drug trials?
MDedge Rheumatology